{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T13:58:30Z","timestamp":1783000710497,"version":"3.54.5"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"University of Shizuoka academic research grant"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"DOI":"10.1007\/s00280-025-04842-0","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T05:29:07Z","timestamp":1768800547000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Analysis of intercellular lipids in the stratum corneum of patients with capecitabine-induced hand-foot syndrome: comparison with the stratum corneum of healthy individuals"],"prefix":"10.1007","volume":"96","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8667-9365","authenticated-orcid":false,"given":"Tomonobu","family":"Uchino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiaki","family":"Nakajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Hatta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikumi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayuko","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rikuto","family":"Terada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunori","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misa","family":"Osawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisei","family":"Taku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasuku","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiki","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Kagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,19]]},"reference":[{"key":"4842_CR1","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.2165\/00003495-200161150-00015","volume":"61","author":"JK McGavin","year":"2001","unstructured":"McGavin JK, Goa KL (2001) Capecitabine. Drugs 61:2309\u20132326. https:\/\/doi.org\/10.2165\/00003495-200161150-00015","journal-title":"Drugs"},{"key":"4842_CR2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.clinthera.2005.01.005","volume":"27","author":"CM Walko","year":"2005","unstructured":"Walko CM, Lindley C (2005) Capecitabine: a review. Clin Ther 27:23\u201344. https:\/\/doi.org\/https:\/\/doi.https:\/\/doi.org\/10.1016\/j.clinthera.2005.01.005","journal-title":"Clin Ther"},{"key":"4842_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/BDD.250","volume":"22","author":"Y Tsukamoto","year":"2001","unstructured":"Tsukamoto Y, Kato Y, Ura M et al (2001) Investigation of 5-FU disposition after oral administration of capecitabine, a triple-prodrug of 5-FU, using a physiologically based pharmacokinetic model in a human cancer xenograft model: comparison of the simulated 5-FU exposures in the tumour tissue between human and xenograft model. Biopharm Drug Dispos 22:1\u201314. https:\/\/doi.org\/10.1002\/BDD.250","journal-title":"Biopharm Drug Dispos"},{"key":"4842_CR4","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1046\/j.1365-2125.2003.01765.x","volume":"55","author":"R Gieschke","year":"2003","unstructured":"Gieschke R, Burger H-U, Reigner B et al (2003) Population pharmacokinetics and concentration\u2013effect relationships of capecitabine metabolites in colorectal cancer patients. Br J Clin Pharmacol 55:252\u2013263. https:\/\/doi.org\/10.1046\/j.1365-2125.2003.01765.x","journal-title":"Br J Clin Pharmacol"},{"key":"4842_CR5","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1517\/14740338.2011.546342","volume":"10","author":"MW Saif","year":"2011","unstructured":"Saif MW (2011) Capecitabine and hand\u2013foot syndrome. Expert Opin Drug Saf 10:159\u2013169. https:\/\/doi.org\/10.1517\/14740338.2011.546342","journal-title":"Expert Opin Drug Saf"},{"key":"4842_CR6","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/j.1365-2125.2008.03159.x","volume":"66","author":"G Milano","year":"2008","unstructured":"Milano G, Etienne-Grimaldi M-C, Mari M et al (2008) Candidate mechanisms for capecitabine-related hand\u2013foot syndrome. Br J Clin Pharmacol 66:88\u201395. https:\/\/doi.org\/10.1111\/j.1365-2125.2008.03159.x","journal-title":"Br J Clin Pharmacol"},{"key":"4842_CR7","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1021\/acs.chemrestox.6b00215","volume":"29","author":"Y Lou","year":"2016","unstructured":"Lou Y, Wang Q, Zheng J et al (2016) Possible pathways of Capecitabine-induced hand\u2013foot syndrome. Chem Res Toxicol 29:1591\u20131601. https:\/\/doi.org\/10.1021\/acs.chemrestox.6b00215","journal-title":"Chem Res Toxicol"},{"key":"4842_CR8","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1523-1747.2002.01706.x","volume":"118","author":"JA Bouwstra","year":"2002","unstructured":"Bouwstra JA, Gooris GS, Dubbelaar FER, Ponec M (2002) Phase behavior of stratum corneum lipid mixtures based on human ceramides: the role of natural and synthetic ceramide 1. J Invest Dermatol 118:606\u2013617. https:\/\/doi.org\/10.1046\/j.1523-1747.2002.01706.x","journal-title":"J Invest Dermatol"},{"key":"4842_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2013.11.006","volume":"1841","author":"J van Smeden","year":"2014","unstructured":"van Smeden J, Janssens M, Gooris GS, Bouwstra JA (2014) The important role of stratum corneum lipids for the cutaneous barrier function. Biochimica et Biophysica Acta (BBA) 1841:295","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"key":"4842_CR10","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1111\/1523-1747.ep12492217","volume":"97","author":"JA Bouwstra","year":"1991","unstructured":"Bouwstra JA, Gooris GS, van der Spek JA, Bras W (1991) Structural investigations of human stratum corneum by small-angle X-ray scattering. J Invest Dermatol 97:1005\u20131012. https:\/\/doi.org\/10.1111\/1523-1747.ep12492217","journal-title":"J Invest Dermatol"},{"key":"4842_CR11","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/0378-5173(92)90158-X","volume":"84","author":"JA Bouwstra","year":"1992","unstructured":"Bouwstra JA, Gooris GS, Salomonsdevries MA et al (1992) Structure of human Stratum-Corneum as a function of temperature and Hydration - a Wide-Angle X-Ray-Diffraction study. Int J Pharm 84:205\u2013216. https:\/\/doi.org\/10.1016\/0378-5173(92)90158-X","journal-title":"Int J Pharm"},{"key":"4842_CR12","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/ics.12162","volume":"36","author":"M Boncheva","year":"2014","unstructured":"Boncheva M (2014) The physical chemistry of the stratum corneum lipids. Int J Cosmet Sci 36:505\u2013515. https:\/\/doi.org\/10.1111\/ics.12162","journal-title":"Int J Cosmet Sci"},{"key":"4842_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s004030100212","volume":"293","author":"A Weerheim","year":"2001","unstructured":"Weerheim A, Ponec M (2001) Determination of stratum corneum lipid profile by tape stripping in combination with high-performance thin-layer chromatography. Arch Dermatol Res 293:191","journal-title":"Arch Dermatol Res"},{"key":"4842_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlr.2022.100235","author":"M Suzuki","year":"2022","unstructured":"Suzuki M, Ohno Y, Kihara A (2022) Whole picture of human stratum corneum ceramides, including the chain-length diversity of long-chain bases. J Lipid Res. https:\/\/doi.org\/10.1016\/j.jlr.2022.100235","journal-title":"J Lipid Res"},{"key":"4842_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/J.PLIPRES.2023.101252","volume":"92","author":"JA Bouwstra","year":"2023","unstructured":"Bouwstra JA, N\u0103d\u0103ban A, Bras W et al (2023) The skin barrier: an extraordinary interface with an exceptional lipid organization. Prog Lipid Res 92:101252. https:\/\/doi.org\/10.1016\/J.PLIPRES.2023.101252","journal-title":"Prog Lipid Res"},{"key":"4842_CR16","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000441540","volume":"49","author":"J van Smeden","year":"2016","unstructured":"van Smeden J, Bouwstra JA (2016) Stratum corneum lipids: their role for the skin barrier function in healthy subjects and atopic dermatitis patients. Curr Probl Dermatol 49:8\u201326. https:\/\/doi.org\/10.1159\/000441540","journal-title":"Curr Probl Dermatol"},{"key":"4842_CR17","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1016\/J.JID.2024.02.010","volume":"144","author":"J Rousel","year":"2024","unstructured":"Rousel J, Mergen C, Schoones JW et al (2024) Similar alterations of the stratum corneum ceramide profile in atopic dermatitis, psoriasis, and ichthyosis: results from a systematic review and meta-analysis. J Invest Dermatol 144:2311-2314e22. https:\/\/doi.org\/10.1016\/J.JID.2024.02.010","journal-title":"J Invest Dermatol"},{"key":"4842_CR18","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/exd.12293","volume":"23","author":"J van Smeden","year":"2014","unstructured":"van Smeden J, Janssens M, Kaye EC et al (2014) The importance of free fatty acid chain length for the skin barrier function in atopic eczema patients. Exp Dermatol 23:45\u201352. https:\/\/doi.org\/10.1111\/exd.12293","journal-title":"Exp Dermatol"},{"key":"4842_CR19","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1038\/jid.2013.517","volume":"134","author":"J Van Smeden","year":"2014","unstructured":"Van Smeden J, Janssens M, Boiten WA et al (2014) Intercellular skin barrier lipid composition and organization in Netherton syndrome patients. J Invest Dermatol 134:1238\u20131245. https:\/\/doi.org\/10.1038\/jid.2013.517","journal-title":"J Invest Dermatol"},{"key":"4842_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.chemphyslip.2023.105305","volume":"254","author":"T Uchino","year":"2023","unstructured":"Uchino T, Kamiya D, Yagi H et al (2023) Comparative analysis of intercellular lipid organization and composition between psoriatic and healthy stratum corneum. Chem Phys Lipids 254:105305. https:\/\/doi.org\/10.1016\/j.chemphyslip.2023.105305","journal-title":"Chem Phys Lipids"},{"key":"4842_CR21","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00280-020-04095-z","volume":"86","author":"T Uchino","year":"2020","unstructured":"Uchino T, Fujino H, Kamiya D et al (2020) Association of dry skin with intercellular lipid composition of stratum corneum after erlotinib administration. Cancer Chemother Pharmacol 86:233\u2013243. https:\/\/doi.org\/10.1007\/s00280-020-04095-z","journal-title":"Cancer Chemother Pharmacol"},{"key":"4842_CR22","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1200\/JCO.2007.14.9898","volume":"26","author":"J Cassidy","year":"2008","unstructured":"Cassidy J, Clarke S, D\u00edaz-Rubio E et al (2008) Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil\/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer. J Clin Oncol 26:2006\u20132012. https:\/\/doi.org\/10.1200\/JCO.2007.14.9898","journal-title":"J Clin Oncol"},{"key":"4842_CR23","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1021\/ac202646v","volume":"84","author":"R T\u2019Kindt","year":"2012","unstructured":"T\u2019Kindt R, Jorge L, Dumont E et al (2012) Profiling and characterizing skin ceramides using reversed-phase liquid chromatography-quadrupole time-of-flight mass spectrometry. Anal Chem 84:403\u2013411. https:\/\/doi.org\/10.1021\/ac202646v","journal-title":"Anal Chem"},{"key":"4842_CR24","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.bpc.2017.03.004","volume":"224","author":"P Pullmannov\u00e1","year":"2017","unstructured":"Pullmannov\u00e1 P, Pavl\u00edkov\u00e1 L, Kov\u00e1\u010dik A et al (2017) Permeability and microstructure of model stratum corneum lipid membranes containing ceramides with long (C16) and very long (C24) acyl chains. Biophys Chem 224:20\u201331. https:\/\/doi.org\/10.1016\/j.bpc.2017.03.004","journal-title":"Biophys Chem"},{"key":"4842_CR25","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.bbamem.2017.01.019","volume":"1859","author":"B \u0160kolov\u00e1","year":"2017","unstructured":"\u0160kolov\u00e1 B, Kov\u00e1\u010dik A, Tesa\u0159 O et al (2017) Phytosphingosine, sphingosine and dihydrosphingosine ceramides in model skin lipid membranes: permeability and biophysics. Biochimica et Biophysica Acta (BBA) 1859:824\u2013834. https:\/\/doi.org\/10.1016\/j.bbamem.2017.01.019","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"key":"4842_CR26","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.biochi.2009.04.001","volume":"91","author":"Y Mizutani","year":"2009","unstructured":"Mizutani Y, Mitsutake S, Tsuji K et al (2009) Ceramide biosynthesis in keratinocyte and its role in skin function. Biochimie 91:784\u2013790. https:\/\/doi.org\/10.1016\/j.biochi.2009.04.001","journal-title":"Biochimie"},{"key":"4842_CR27","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1016\/S0022-2275(20)32369-5","volume":"41","author":"Y Uchida","year":"2000","unstructured":"Uchida Y, Hara M, Nishio H et al (2000) Epidermal sphingomyelins are precursors for selected stratum corneum ceramides. J Lipid Res 41:2071\u20132082. https:\/\/doi.org\/10.1016\/S0022-2275(20)32369-5","journal-title":"J Lipid Res"},{"key":"4842_CR28","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1046\/j.1523-1747.2002.01836.x","volume":"119","author":"S Hamanaka","year":"2002","unstructured":"Hamanaka S, Suzuki A, Hara M et al (2002) Human epidermal glucosylceramides are major precursors of stratum corneum ceramides. J Invest Dermatol 119:416\u2013423. https:\/\/doi.org\/10.1046\/j.1523-1747.2002.01836.x","journal-title":"J Invest Dermatol"},{"key":"4842_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-62823-0","volume":"10","author":"JH Jung","year":"2020","unstructured":"Jung JH, Taniguchi K, Lee HM et al (2020) Comparative lipidomics of 5-Fluorouracil\u2013sensitive and \u2013resistant colorectal cancer cells reveals altered sphingomyelin and ceramide controlled by acid sphingomyelinase (SMPD1). Sci Rep 10:6124. https:\/\/doi.org\/10.1038\/s41598-020-62823-0","journal-title":"Sci Rep"},{"key":"4842_CR30","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.3390\/cancers13102475","volume":"13","author":"M Sheridan","year":"2021","unstructured":"Sheridan M, Ogretmen B (2021) The role of ceramide metabolism and signaling in the regulation of mitophagy and cancer therapy. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers13102475","journal-title":"Cancers (Basel)"},{"key":"4842_CR31","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1194\/jlr.P030338","volume":"53","author":"M Janssens","year":"2012","unstructured":"Janssens M, van Smeden J, Gooris GS et al (2012) Increase in short-chain ceramides correlates with an altered lipid organization and decreased barrier function in atopic eczema patients. J Lipid Res 53:2755","journal-title":"J Lipid Res"},{"key":"4842_CR32","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.addr.2003.10.025","volume":"56","author":"AC Williams","year":"2004","unstructured":"Williams AC, Barry BW (2004) Penetration enhancers. Adv Drug Deliv Rev 56:603\u2013618. https:\/\/doi.org\/https:\/\/doi.https:\/\/doi.org\/10.1016\/j.addr.2003.10.025","journal-title":"Adv Drug Deliv Rev"},{"key":"4842_CR33","doi-asserted-by":"publisher","first-page":"6534","DOI":"10.1021\/la500972w","volume":"30","author":"EH Mojumdar","year":"2014","unstructured":"Mojumdar EH, Helder RWJ, Gooris GS, Bouwstra JA (2014) Monounsaturated fatty acids reduce the barrier of stratum corneum lipid membranes by enhancing the formation of a hexagonal lateral packing. Langmuir 30:6534\u20136543. https:\/\/doi.org\/10.1021\/la500972w","journal-title":"Langmuir"},{"key":"4842_CR34","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1038\/jid.2011.175","volume":"131","author":"M Janssens","year":"2011","unstructured":"Janssens M, Van Smeden J, Gooris GS et al (2011) Lamellar lipid organization and ceramide composition in the stratum corneum of patients with atopic eczema. J Invest Dermatol 131:2136\u20132138. https:\/\/doi.org\/10.1038\/jid.2011.175","journal-title":"J Invest Dermatol"},{"issue":"12","key":"4842_CR35","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1096\/fba.2019-00067","volume":"1","author":"M Isokawa","year":"2019","unstructured":"Isokawa M, Sassa T, Hattori S et al (2019) Reduced chain length in myelin sphingolipids and poorer motor coordination in mice deficient in the fatty acid elongase Elovl1. FASEB Bioadv 1(12):747\u2013759. https:\/\/doi.org\/10.1096\/fba.2019-00067","journal-title":"FASEB Bioadv"},{"key":"4842_CR36","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.00192-13","volume":"33","author":"T Sassa","year":"2013","unstructured":"Sassa T, Ohno Y, Suzuki S et al (2013) Impaired epidermal permeability barrier in mice lacking Elovl1, the gene responsible for very-long-chain fatty acid production. Mol Cell Biol 33:2787","journal-title":"Mol Cell Biol"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-025-04842-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00280-025-04842-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-025-04842-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T18:03:50Z","timestamp":1768845830000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00280-025-04842-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,19]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4842"],"URL":"https:\/\/doi.org\/10.1007\/s00280-025-04842-0","relation":{},"ISSN":["1432-0843"],"issn-type":[{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,19]]},"assertion":[{"value":"3 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol was approved by the Institutional Review Board of Shizuoka General Hospital (approval number: SGH#2019098) and the University of Shizuoka (approval number: 1-68). Informed consent was obtained from all the participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Consent for publication"}}],"article-number":"8"}}